Yunzheng K. Li
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Intratumoral Proton Density Fat Fraction Predicts the Outcome of HAIC Combined With PD-1 Inhibitors in Advanced Hepatocellular Carcinoma.
Journal: Cancer medicine
Published: November 11, 2025
β-catenin mutation reprograms ketone body metabolism to drive hepatocellular carcinoma metastasis and resistance to ketogenic therapy via transcriptional activation of OXCT1.
Journal: Cell death & disease
Published: March 20, 2025
S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3/PD-L1 pathway.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 16, 2025
Fat fraction quantification by MRI predicts diagnosis and prognosis of HBV-related steatohepatitic hepatocellular carcinoma.
Journal: European radiology
Published: August 30, 2024
Letter to the Editor: Molecular classification based on multi-omics facilitates prognostic stratification and personalized treatment in hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: April 26, 2024
HOXA9 promotes proliferation, metastasis and prevents apoptosis in hepatocellular carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: March 21, 2024
Liver Regeneration-Related Genes of Nontumor Liver Tissues Predict the Prognosis of Patients with Hepatocellular Carcinoma.
Journal: Journal of hepatocellular carcinoma
Published: September 08, 2023
Comparison of intraoperative neurophysiological monitoring between patients with arthrogryposis multiplex congenita and adolescent idiopathic scoliosis
Journal: Zhonghua yi xue za zhi
Published: June 12, 2023
Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical function.
Journal: Cell death and differentiation
Published: February 20, 2023
Last Updated: 09/26/2026